Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
trending now
trending in pharma/biotech
trending in device
pharmagather
advertise
Legal Help
login/register
You are here
Home
»
companies
» Lonsurf
Lonsurf
Phase III Trial Data Demonstrates Significant Overall Survival Benefit of Lonsurf (trifluridine and tipiracil) in Patients with Metastatic Gastric Cancer
Phase III Trial Data Demonstrates Significant Overall Survival Benefit of Lonsurf (trifluridine and tipiracil) in Patients with Metastatic Gastric Cancer
CP Wire
Servier
Taiho Pharmaceutical
Lonsurf
gastric cancer
Flag link:
Phase III Trial Data Demonstrates Significant Overall Survival Benefit of Lonsurf (trifluridine and tipiracil) in Patients with Metastatic Gastric Cancer
Servier
Taiho Pharmaceutical
Lonsurf
gastric cancer
Flag link:
FDA approves Taiho Oncology's pill for metastatic colorectal cancer
FDA approves Taiho Oncology's pill for metastatic colorectal cancer
BioPharma Dive
FDA
metastatic colorectal cancer
Taiho Oncology
Lonsurf
Flag link:
